Terns Pharmaceuticals, Inc. (TERN) Tops Q1 EPS by 4c

Terns Pharmaceuticals, Inc. (NASDAQ: TERN) reported Q1 EPS of ($0.26), $0.04 better than the analyst estimate of ($0.30).

For earnings history and earnings-related data on Terns Pharmaceuticals, Inc. (TERN) click here.

You May Also Be Interested In

• Barclays Starts DKSH Holding AG (DKSH:SW) at Overweight
• South Korea's KOSPI Plunges 8%, Triggering Circuit Breaker
• JPMorgan Starts ICICI Prudential Asset Management (ICICIAMC:IN) at Overweight